rasagiline has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, Y; Lan, JS; Liu, L; Liu, Y; Xie, SS; Yang, J; Yang, YT; Zeng, RF; Zhang, T | 1 |
| Gao, CM; Yang, XL | 1 |
| Amit, T; Mandel, SA; Sagi, Y | 1 |
1 review(s) available for rasagiline and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway.
Topics: Animals; Enzyme Activation; Gene Expression; Indans; MPTP Poisoning; Nerve Regeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Rats; Receptor, trkB; Signal Transduction; Substantia Nigra | 2007 |
2 other study(ies) available for rasagiline and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
Topics: Animals; Coumarins; Drug Design; Indans; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Oxidopamine; PC12 Cells; Protein Conformation; Rats; Rotenone; Structure-Activity Relationship | 2021 |
c‑Jun N‑terminal kinase 3 signalling serves a potential role as a biomarker for determining the pathogenesis of Parkinson's disease.
Topics: Animals; Biomarkers; Caspase 3; Disease Models, Animal; Down-Regulation; Immunohistochemistry; Indans; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 10; MPTP Poisoning; Severity of Illness Index; Up-Regulation | 2018 |